NCT06589869 Effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the Treatment of SUI in Chinese Men Undergone Robotic Radical Prostatectomy
| NCT ID | NCT06589869 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Urinary Incontinence , Stress |
| Study Type | INTERVENTIONAL |
| Enrollment | 184 participants |
| Start Date | 2022-07-29 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 184 participants in total. It began in 2022-07-29 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, randomized trial to evaluate the efficacy and safety of High-Intensity Focused Electromagnetic (HIFEM) Technology in the treatment of stress urinary incontinence compared with standard of care in Chinese men who had undergone robotic radical prostatectomy.
Eligibility Criteria
Inclusion Criteria: * Undergone robotic radical prostatectomy * Able to carry out 1-hour pad test * Voluntary participation and signing of the informed consent form Exclusion Criteria: * Pre-existing stress urinary incontinence * Post-void residual urine greater than 200ml * Active urinary tract infection * Urethral or bladder fistula * History of pelvic irradiation * Neurological condition (Spinal cord problems, stroke with poor neurological recovery, epilepsy, Parkinson disease, multiple sclerosis) * Previous surgery for SUI * Concurrent medication with diuretics, serotonin-norepinephrine reuptake inhibitors or any other medication known to worsen incontinence * Condition contraindicated for electromagnetic therapy i.e. Arrhythmia, on a pacemaker or implanted metallic device; Coagulopathy or on anticoagulant
Contact & Investigator
Chi Fai NG, MD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT06589869 clinical trial?
This trial is open to male participants only, aged 18 Months or older, studying Urinary Incontinence , Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06589869 currently recruiting?
Yes, NCT06589869 is actively recruiting participants. Contact the research team at ngcf@surgery.cuhk.edu.hk for enrollment information.
Where is the NCT06589869 trial being conducted?
This trial is being conducted at Shatin, Hong Kong.
Who is sponsoring the NCT06589869 clinical trial?
NCT06589869 is sponsored by Chinese University of Hong Kong. The principal investigator is Chi Fai NG, MD at Chinese University of Hong Kong. The trial plans to enroll 184 participants.